DOXIL LIPOSOME INJECTION
Alembic Pharmaceuticals gets USFDA nod for generic cancer treatment injectionAlembic Pharmaceuticals has received final USFDA approval. This approval is for its generic Doxorubicin Hydrochloride Liposome injection. T...
Alembic Pharma shares rally 12% on USFDA nod for cancer drugAlembic Pharmaceuticals surged 12% to Rs 1,089.80 after securing USFDA approval for its generic Doxorubicin Hydrochloride Liposome Injectio...
Lupin launches generic cancer drug in USLupin has launched a generic cancer treatment drug, Doxorubicin Hydrochloride Liposome Injection, in the US market. The product is a generi...
Sun Pharma hits all-time high as rival announces shortage of cancer drugSun Pharmaceuticals hit an all-time high on hopes that the company will benefit after rival Janssen announced shortage of Doxil in US.- Sun Pharma receives USFDA nod for anti-cancer injectionSun Pharmaceutical Industries today said it has received US health regulator's approval to market generic version of Doxil injection.
Load More